| EPLIN | Epithelial protein lost in neoplasm |
| LIMA1 | LIM domain and actin-binding 1 |
| LIM | Lin-11, Isl-1, and Mec-4 |
| LUZP1 | Leucine zipper protein1 |
| ARP2 | Actin-related protein |
| NPC1L1 | NPC1-Like Intracellular Cholesterol Transporter 1 |
| APOA5 | Apolipoprotein A-5 |
| ΔΨm | Mitochondrial transmembrane potential |
| AMPK | AMP-activated protein kinase |
| EDAC | Epithelial defense against cancer |
| Src | Proto-oncogene tyrosine protein kinase |
| Cav-1 | Caveolin-1 |
| PKA | Protein kinase A |
| EDAC | Epithelial defense against cancer |
| HDAC6 | Histone deacetylates 6 |
| MAD2 | Mitotic arrest deficient 2 |
| EMT | Epithelial–mesenchymal transition |
| HUVECs | Human umbilical vein endothelial cells |
| HCC | Hepatocellular carcinoma |
| TERT | Telomerase reverse transcriptase |
| MALT-lymphoma | Mucosa-associated lymphoid tissue lymphoma |
| API2 | Apoptosis inhibitor 2 |
| API2-MALT1 | Apoptosis inhibitor 2-MALT lymphoma translocation gene 1 |
| HNSCC | Head and neck squamous cell carcinoma |
| NAC | Neoadjuvant chemotherapy |
| OSCC | Esophageal squamous cell carcinoma |
| OAC | Adenocarcinoma |